Therapy News and Research

RSS

Outsourcing trend emerging in health care industry

Outsourcing, an established but fairly static practice in the U.S. health care industry, may grow in scope as the country experiences major shifts in health care delivery.

3 Aug 2012

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Gilead Sciences Inc. announced Thursday that it plans to partner with Mylan Inc., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd. "to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine in developing countries," the Wall Street Journal reports.

3 Aug 2012

AD hits hardest among people in their 60s and 70s

The greatest risk factor for Alzheimer's disease (AD) is advancing age. By age 85, the likelihood of developing the dreaded neurological disorder is roughly 50 percent. But researchers at the University of California, San Diego School of Medicine say AD hits hardest among the "younger elderly" - people in their 60s and 70s - who show faster rates of brain tissue loss and cognitive decline than AD patients 80 years and older.

3 Aug 2012

Sta Op Tegen Kanker International Translational Cancer Research Grant recipients announced

Stand Up To Cancer (SU2C) and the Dutch Cancer Society (KWF Kankerbestrijding), along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announce the recipients of the Sta Op Tegen Kanker International Translational Cancer Research Grant.

3 Aug 2012

Clinicians need to discuss disorders of consciousness with ethical sensitivity

New tools have confirmed high rates of misdiagnosis of patients with chronic disorders of consciousness, such as the vegetative state. An increasing number of patients' families wish to use these novel techniques for diagnosis, prognosis, and treatment.

3 Aug 2012

Skin cell spray key to venous leg ulcer treatment

A spray consisting of a mixture of keratinocyte and fibroblast skin cells holds promise for treatment of venous leg ulcers, show results from a phase II randomized controlled trial published in The Lancet.

3 Aug 2012

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

The once-daily integrase inhibitor dolutegravir has shown promise in a phase III noninferiority study comparing it with twice-daily raltegravir for treatment of HIV-1, indicate study results presented at the 19th International AIDS Conference in Washington DC, USA.

3 Aug 2012

Study finds evidence that smoking cessation is more difficult for women than men

A recent study challenged an enduring belief that women were less successful than men in quitting smoking. The study, published in the journal Tobacco Control, found convincing evidence that across all of the age groups, "there is relatively little difference in cessation between the sexes."

3 Aug 2012

Fatty acid synthase provides new target for treatment of obesity and diabetes

Researchers at Washington University School of Medicine in St. Louis have identified a potential target for treating diabetes and obesity.

3 Aug 2012

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Healthpoint Biotherapeutics today announced that the results for its Phase 2b clinical trial investigating the efficacy of HP802-247 in venous leg ulcers is published on The Lancet, beginning August 3, 2012, with Online First access to the article, followed by print publication in the next issue.

3 Aug 2012

Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients

Sanford Project researchers have reached a critical milestone in a clinical trial testing a combination of two medications to determine if the drugs can help patients with type 1 diabetes (T1D) keep their blood glucose levels under control with less or no insulin. The full number of patients needed to complete this first trial, termed Restore Pancreatic Insulin Response in type 1 diabetes (REPAIR-T1D), has been reached.

2 Aug 2012

BMC to implement and evaluate opioid risk reduction model in primary care settings

Researchers at Boston Medical Center (BMC) have received a $2.67 million grant from the National Institute on Drug Abuse (NIDA) to implement and evaluate a new model of care in primary care settings aimed at decreasing the misuse of and addiction to opioids among patients with chronic pain.

2 Aug 2012

PTSD prevalent in serious mental illness patients

Post-traumatic stress disorder is common among patients with serious mental illnesses, and is associated with an increased risk for suicide attempts, Spanish researchers report.

2 Aug 2012

OCS common in patients at high risk for psychosis

Obsessive–compulsive symptoms are common in patients at high risk for psychosis and are associated with an increased risk for suicidal ideation, US study results show.

2 Aug 2012

MDCH unveils Michigan’s Infant Mortality Reduction Plan

The Michigan Department of Community Health (MDCH) has unveiled the state's Infant Mortality Reduction Plan, a strategy that includes significant recommendations developed from medical research conducted by the Perinatology Research Branch (PRB) of the Eunice Kennedy Shriver National Institute for Child Health and Human Development, National Institutes of Health (NICHD/NIH), at the Wayne State University School of Medicine.

2 Aug 2012

Combination hormonal therapy improves survival in advanced breast cancer

A study co-authored by a Loyola researcher and published in the New England Journal of Medicine is offering new hope to women with advanced breast cancer.

2 Aug 2012

New insight into why glioblastoma multiforme recurs in adults

A study by UT Southwestern Medical Center researchers published online today in Nature reveals new insight into why the most common, deadly kind of brain tumor in adults recurs and identifies a potential target for future therapies.

2 Aug 2012

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metastatic breast cancer by more than six months compared to women treated with a standard therapy of anastrozole alone (47.7 months vs 41.3 months).

2 Aug 2012

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Scientists have known for some time that throwing off the body's circadian rhythm can negatively affect body chemistry. In fact, workers whose sleep-wake cycles are disrupted by night shifts are more susceptible to chronic inflammatory diseases such as diabetes, obesity and cancer.

2 Aug 2012

Researchers develop bioactive coating that actively suppresses brain's immune response

Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.

1 Aug 2012

Therapy News and Research

Outsourcing trend emerging in health care industry

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

AD hits hardest among people in their 60s and 70s

Sta Op Tegen Kanker International Translational Cancer Research Grant recipients announced

Clinicians need to discuss disorders of consciousness with ethical sensitivity

Skin cell spray key to venous leg ulcer treatment

Novel integrase inhibitor dolutegravir shows promise for HIV-1 treatment

Study finds evidence that smoking cessation is more difficult for women than men

Fatty acid synthase provides new target for treatment of obesity and diabetes

Healthpoint Biotherapeutics announces results from HP802-247 Phase 2b trial on venous leg ulcers

Combination of sitagliptin and lansoprazole offers clinical benefits for T1D patients

BMC to implement and evaluate opioid risk reduction model in primary care settings

PTSD prevalent in serious mental illness patients

OCS common in patients at high risk for psychosis

MDCH unveils Michigan’s Infant Mortality Reduction Plan

Combination hormonal therapy improves survival in advanced breast cancer

New insight into why glioblastoma multiforme recurs in adults

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Researchers develop bioactive coating that actively suppresses brain's immune response

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News